VELTIP 2MG INJECTION 2ML Substitute

VELTIP 2MG INJECTION 2ML contains the active substance bortezomib, also-called ‘proteasome inhibitor. Proteasomes play an important role in controlling cell function and growth. By interfering with their function, thereby it can kill cancer cells.

VELTIP 2MG INJECTION 2ML is prescribed by a doctor experienced in the use of medications to treat cancer. It is administered by a healthcare professional as an injection into your vein (intravenously or IV) or under your skin (subcutaneously, or SC). VELTIP 2MG INJECTION 2ML must not be administered into your spinal fluid (intrathecally).

Yes, VELTIP 2MG INJECTION 2ML can cause low neutrophils levels, a type of white blood cells that help fight infections. If your white blood cells become low, you can be at higher risk for infections. Tell your doctor if you develop a fever or believe you have an infection.

Avoid taking VELTIP 2MG INJECTION 2ML if you are pregnant because VELTIP 2MG INJECTION 2ML can cause harmful effects on the unborn baby. Females should follow effective birth control methods during treatment and at least six months after the final dose of VELTIP 2MG INJECTION 2ML.

Before you receive treatment with VELTIP 2MG INJECTION 2ML, tell your doctor about all of your medical conditions. You should not receive VELTIP 2MG INJECTION 2ML if you are allergic to bortezomib or any contents in VELTIP 2MG INJECTION 2ML.